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A B S T R A C T
Genome sequencing of virus has become a useful tool for better understanding of virus pathogenicity and epi-
demiological surveillance. Obtaining virus genome sequence directly from clinical samples is still a challenging
task due to the low load of virus genetic material compared to the host DNA, and to the diﬃculty to get an
accurate genome assembly. Here we introduce a complete sequencing and analyzing protocol called V-ASAP for
Virus Amplicon Sequencing Assembly Pipeline. Our protocol is able to generate the viral dominant genome
sequence starting from clinical samples. It is based on a multiplex PCR amplicon sequencing coupled with a
reference-free analytical pipeline. This protocol was applied to 11 clinical samples infected with coronavirus
OC43 (HcoV-OC43), and led to seven complete and two nearly complete genome assemblies. The protocol
introduced here is shown to be robust, to produce a reliable sequence, and could be applied to other virus.
1. Introduction
When an outbreak occurred in a health-care setting, identiﬁcation of
the causative pathogen and epidemiological investigations need to be
fast and eﬀective to allow a targeted infection control response. During
viral outbreaks, molecular diagnosis methods as real-time RT/PCR
allow identifying the pathogen and eventually the index case of the
outbreak. However, the outbreak investigation must also determine
clusters of patients and the pathway of the dissemination of the cau-
sative agent to stop the viral dissemination. Until now, Sanger se-
quencing method is used to obtain partial sequence of viral genome
necessary to identify clusters of cases. However, many technical lim-
itations, especially the small amount of viral genome in the biological
samples, make this approach not very eﬀective for the management of
the outbreak. High-throughput sequencing (HTS) technologies provide
the possibility to rapidly obtain the full sequence of pathogen genomes.
Notably whole-genome sequencing (WGS) of viruses is a powerful tool
for the development of novel treatments and vaccines, for studying
virus evolution and genetic association to diseases or for tracking out-
breaks. Recently, HTS has been used to investigate viral outbreaks in
health-care settings (Garvey et al., 2017; Houlihan et al., 2018;
Vaughan et al., 2014). The depth of the sequencing data and the quality
of the obtained sequences make this tool particularly eﬃcient in this
context. However, despite the relative small size of virus genomes, their
sequencing often remains diﬃcult. The small amount of virus genetic
material compare to the host nucleic acid decreases viral sequencing
output. In addition, one have to deal with the diﬃculty that several
viral variants coexist in a single sample, presenting more or less vari-
able sequences depending on the intrinsic mutation rate of the virus. All
these points burden the sequencing and the assembly of viral genome.
Today, numerous hospital laboratories have immediate access to HTS
methods but the bioinformatics analysis remains diﬃcult without
bioinformatics skills. Consequently developing eﬀective and easy-to-use
protocols is a new challenge for the spreading of HTS methods as tools
to investigate viral outbreaks in hospital.
Three main methods based on HTS are currently used for viral
whole-genome sequencing: metagenomic sequencing, target enrich-
ment sequencing and PCR amplicon sequencing, each showing beneﬁts
and drawbacks (Houldcroft et al., 2017). In metagenomic sequencing,
total DNA (and/or RNA) from a sample including host but also bacteria,
viruses and fungi is extracted and sequenced. It is a simple and cost-
eﬀective approach, and it is the only approach not requiring reference
sequences. Instead, the other two HTS approaches, target enrichment
and amplicon sequencing, both depend on reference information to
design baits or primers. The limitation of metagenomic sequencing is
that it requires a very high sequencing depth to obtain enough viral
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genome material. The target enrichment sequencing uses virus-speciﬁc
capture oligonucleotides to enrich the viral genome preparation before
sequencing. This method is more speciﬁc than metagenomics sequen-
cing but implies higher costs and a more advanced technical expertise
for sample preparation. Finally, the PCR amplicon sequencing is a well-
established method consisting in speciﬁc viral genome ampliﬁcation by
PCR before sequencing. It is easily applicable on large number of
samples in a routine use and so very adequate for clinical samples. The
PCR ampliﬁcation method, compared to the others, is particularly re-
levant for samples containing very low viral genetic material, it pre-
sents several disadvantages, though. The sequence of the virus of in-
terest has to be known and not too variable to be correctly ampliﬁed by
the set of designed primers. A second pitfall is due to the fact that the
PCR cycles can introduce some ampliﬁcation errors along the sequence
which make the assembly step more prone to mistakes. Finally, this
method can only be used for small genomes because of the number of
PCR reactions which has to be limited.
A new protocol based on multiplex PCR method was recently in-
troduced for virus sequencing (Quick et al., 2017) to obtain consensus
genome sequences directly from samples. They showed that the num-
bers of reads with metagenomic approaches is often very low for Zika
virus and applied the multiplex PCR method successfully. This in-
novative approach allows to rapidly (1–2 days) obtain a consensus se-
quence directly from clinical samples loaded with as few as 50 genome
copies per reaction. This method is of great interest during outbreak
and can also be used as an inexpensive and convenient method in the
lab. However, it was not tested for viral genomes larger than 12 kb.
Moreover, the authors also introduced in this study an analytical pi-
peline to obtain the consensus sequence from the alignment of reads
against a reference sequence in addition to the complete and optimized
sequencing protocol.
The bioinformatics analysis of virus sequencing data is often based
on alignment, or mapping, of reads against a reference sequence fol-
lowed by the consensus extraction by majority voting. However, the
alignment step is known to introduce some biases (Archer et al., 2010;
Posada-Cespedes et al., 2017). For example, if the studied virus se-
quence is divergent from the chosen reference sequence, the reads
covering the regions of divergence could not be aligned correctly which
Fig. 1. Schematic representation of the complete protocol for viral sequencing directly from clinical samples.
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will bias the resulting consensus. Moreover, the mapping step of reads
in divergent, repetitive or low complexity regions is a diﬃcult task
which have to be carefully examined (Caboche et al., 2014). Finally, the
choice of the reference sequence itself is a critical step from which the
resulting consensus sequence will strongly depend.
Here we present an innovative complete protocol to rapidly obtain
viral dominant sequence for a routine use in clinical context. This
protocol is based on multiplex PCR amplicon sequencing. A set of re-
ference sequences representative of the studied virus is required in
order to identify conserved regions and design a set of primers. We also
introduce a new analysis pipeline called V-ASAP for Virus Amplicon
Sequencing Assembly Pipeline, which is able to build the dominant
genome sequence from amplicon sequencing data without requiring
any alignment step and so without having to choose a reference se-
quence. V-ASAP was ﬁrst evaluated with data from sequencing of Zika
virus (Quick et al., 2017) and then applied to sequence viral RNA ex-
tracted from 11 samples obtained from patients infected with OC43
coronaviruses (HCoV-OC43) and isolated at the University Hospital of
Lille (France) from nasal swab or broncho-alveolar lavage. Belonging to
the family of Coronaviridae and to the genus betacoronavirus, HCoV-
OC43 are among the known viruses that cause the common cold, but
can also cause severe lower respiratory tract infections, including
pneumonia in infants, in elderly and in immunocompromised in-
dividuals. Coronaviruses are enveloped viruses possessing a positive
single-stranded RNA genome with a length between 26.2 and 31.7 kb
(ICTV taxonomy https://talk.ictvonline.org/p/coronavirus-genomes).
Despite of the low load of HCoV-OC43 in samples and the relative high
size of the genome sequence (30 kb), our protocol allowed to obtain
fully ﬁnished genomes for 7 out of the 11 clinical samples. For 2 other
genomes, 2 and 8 contigs were obtained covering respectively more
than 99% and 94% of the entire genome.
2. Results and discussion
2.1. Protocol description
The complete protocol is schematically represented in Fig. 1. The
ﬁrst step consists in designing of overlapping primer pairs to cover the
entire genome (Fig. 1, step 1). The next step (Fig. 1, step 2) is the
ampliﬁcation and sequencing of fragments which could be performed
with Illumina paired-end library protocol allowing to obtain reads of
300 bp.
The analysis begins with the paired-end read merging step (Fig. 1,
step 3) performed with CASPER (Kwon et al., 2014) and leading to
reads of 500–550 bp. Each merged read is then assigned to its amplicon
of origin. For this assignment, the PCR primers are used as barcodes in a
demultiplexing strategy using Cutadapt (Martin, 2011). At the end of
this step (Fig. 1, step 4), the number of reads per amplicon is known:
some amplicons could be over-sequenced and some others under-re-
presented. For each amplicon, several diﬀerent sequences co-existed
due to the presence of viral variants and sequencing errors. At this step,
we postulated that the most abundant read represents the dominant
variant of the population for each amplicon. Our method is slightly
diﬀerent from the one usually used when the consensus sequence is
generated from alignment with the majority voting strategy. Indeed, in
consensus extraction method the columns of the alignment are con-
sidered as independent one to another and the majority base is selected
whereas in our method the whole amplicon sequence is taking into
account which could result in diﬀerent calling sequence. Fig. 2 shows
an example of diﬀerent calling results between the two methods.
When a dominant genome exists in population but with a proportion
lower than 50%, the two methods can return diﬀerent sequences. For
example in Fig. 2, if the dominant genome, representing 1/3 in popu-
lation, carries a G and all the other variants carry an A at this position,
our method will return the G from the dominant variant whereas the
consensus method will vote for A at this position which is the major
base at this position. However, in the case where a dominant variant
represents more than 50% in population, the two methods become
equivalent and produce the same ﬁnal sequence. To identify the most
abundant variant sequence for each amplicon (Fig. 1, step 5), a clus-
tering step at 100% identity to group and count identical reads is per-
formed using CD-hit (Fu et al., 2012). In the ﬁnal step of the protocol
(Fig. 1, step 6), the most abundant read for each amplicon is used as the
representative fragment for the assembly step performed using CAP3
(Huang and Madan, 1999) leading to the dominant genome sequence.
V-ASAP is freely available on gitub https://github.com/caboche/V-
ASAP as a docker container. Parameters used for each program are
detailed in the Material and Methods section.
2.2. Validation of V-ASAP on Zika virus
To validate our analytical method, we used an available public data
on Zika virus (Quick et al., 2017). In this study, 35 primer pairs were
designed and the PCR products were sequenced with Illumina over-
lapping paired-end reads leading to 35 amplicons of 400 bp covering
the entire genome of Zika virus (around 10,300 bp). These data were
comparable with the data produced in our protocol and the complete
genome sequences obtained by the authors were available making this
study a good validation dataset.
We applied V-ASAP to this dataset and compared the results with
the sequences obtained from the classical method consisting in aligning
reads against a reference sequence and extracting a consensus sequence
from this alignment (see section “Material and methods - Validation on
Zika virus” for more details about the selection of reference sequences
and parameters for both approaches). We used four diﬀerent reference
sequences (KU853012.1, HQ224499.1, HQ234501.1, KF268948.1) for
the alignment-based method in order to study the impact of the re-
ference sequence selection. These four reference sequences were se-
lected for presenting an increasing phylogenetic distance from the se-
quenced viruses (see Supplementary material part 1 for the
phylogenetic tree). The results are shown in Table 1.
As expected, the results showed that the consensus sequences ob-
tained with alignment-based method varied a lot depending on the
selected reference sequence: the more the reference and studied se-
quences were close the better were the results. With the closest re-
ference sequence (KU853012.1), the results of the three assemblies
were reliable: more than 96% of the sequence was covered in 2 or 3
contigs with very few errors (insertions, deletions or mismatches). Only
one mismatch was observed for the consensus sequence generated with
SRR5121076 dataset. This error in consensus calling was due to a
misalignment of several reads in this region: the ends of a number of
reads at this position did not align, probably due to an incorrect trim-
ming of these reads in the original dataset. This example showed that
the correct alignment of reads is necessary to call the correct consensus
Fig. 2. Diﬀerence observed between sequences generated from alignment
combined with consensus extraction and full-amplicon based extraction.
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and that the alignment step has to be very carefully performed, an in-
correct trimming or an incorrect parameters tuning could have a strong
impact on results. When the reference sequence was divergent from the
studied sequence, the quality of the obtained consensus sequence ra-
pidly fall down. The coverage decreased (around 90% with HQ234499.
1 and only around 20% with the more distant sequences HQ234501.1
and KF268948.1). Moreover the assembly became very fragmented
with an increasing number of contigs. Another interesting feature was
the number of unaligned contigs, i.e. contigs produced by the method
but which did not align against the true sequence. This number in-
creased dramatically when the reference sequence was more divergent.
This was due to the well-known over-ﬁtting bias of the alignment-based
method (Archer et al., 2010): some bases of the reference sequence
were selected in place of the true bases from reads because of incorrect
alignment of reads. The reference-free method used in V-ASAP resulted
in sequences close to the expected ones with metrics similar to the one
obtained with the closest reference sequence. The assembly covered
more than 95% of the sequence with only 2 or 3 contigs and without
any errors for the three datasets. The sequence produced with align-
ment-based method with the closest reference was a little longer (be-
tween 0% and 2%) compared to the sequence obtained with V-ASAP.
This diﬀerence was due to bad trimming of some reads which were
longer than the amplicon sizes. This bad-trimmed reads were not con-
sidered in V-ASAP but were in the alignment-based approach leading to
additional bases in the consensus sequence. All the results showed that
V-ASAP avoid biases due to the alignment step, and even if a close
reference sequence is not available, our pipeline is able to produce a
relevant sequence which is not the case, as demonstrated here, with
alignment-based methods.
2.3. Development and validation of the protocol for HCoV-OC43
The goal of this study was to directly sequence clinical samples from
patients infected with HCoV-OC43 isolated at the University Hospital of
Lille (France) from nasal swab (noted ‘MDSX’) or bronco-alveolar la-
vage (noted ‘PR2’) with a protocol that could be used in routine clinical
context. HCoV-OC43 has a genome of more than 30 kb and some
development, optimization and validation steps were necessary.
Choice of the amplicon length
Several sequencing-based methods were used to obtain HCoV-OC43
full-length genomes. Sanger sequencing was the ﬁrst method used with
variable size of ampliﬁed regions (St-Jean et al., 2004; Vijgen et al.,
2005). Targeted viral nucleic acid capture and RNA sequencing library
was recently used to sequence four human HCoV-OC43 isolates
(Dinwiddie et al., 2018). The most usual method is to divide the
genome into 2.5 kb regions which are ampliﬁed, fragmented and se-
quenced with HTS technologies (Cotten et al., 2013; Taboada et al.,
2016). However, depending on the viral load and on the RNA quality,
the ampliﬁcation of the 2.5 kb genome fragments could be troublesome.
We tested the possibility to amplify long viral genome fragments from
HCoV-OC43 infected samples by testing RT-PCR ampliﬁcations of dif-
ferent lengths, from ~500 bp to ~5000 bp with an increment-step of
~500 bp (see Supplementary material part 2 for more details). The
Fig. 3 shows the ampliﬁcation results on two testing clinical samples
used for protocol setting which were chosen to be representative of the
other clinical samples to be analyzed in this study. Speciﬁc ampliﬁed
fragments were only obtained for short lengths (below ~2000 bp). The
ﬁrst testing sample gave only ampliﬁcation for products between
~500 bp and ~2000 bp and the second sample only gave ampliﬁcations
till the ~1500 bp fragment. The fact that no ampliﬁcation was detected
above ~2000 bp illustrates the disqualiﬁcation of an approach which
would start by a long range PCR. The 500 bp fragment size could be
ampliﬁed for the two testing samples with a good eﬃciency showing
that viral regions of 500 bp had a high probability to be ampliﬁed. In
addition, fragment of 500 bp were of technical interest as they could be
directly sequenced with 300 bp Illumina paired-end overlapping reads.
We therefore decided to divide the genome into ~500 bp overlapping
fragments.
Primer design and grouping for PCR multiplex
To generate a reliable consensus sequence on which to design
Table 1
Output comparison of V-ASAP and alignment-based approach using diﬀerent reference sequences.
Method V-ASAP Alignment Alignment Alignment Alignment
Reference sequence None KU853012.1 HQ234499.1 HQ234501.1 KF268948.1
SRR5121076 (KY317939 – 10608 bp)
# contigs 2 2 2 32 33
Total length 10162 10450 9546 2722 2889
N50 5254 5275 4923 115 111
# unaligned contigs 0 0 0 13 14
Genome fraction (%) 95.796 98.482 89.989 21.380 20.249
# Ns 0 3 10 3 8
# mismatches 0 1 0 0 0
# indels 0 0 0 0 0
SRR5121078 (KY317936 – 10389 bp)
# contigs 3 3 7 28 29
Total length 9965 10,061 8876 2340 2449
N50 5254 5255 4584 115 111
# unaligned contigs 0 0 1 12 11
Genome fraction (%) 95.919 96.843 85.388 18.433 18.760
# Ns 0 0 0 1 23
# mismatches 0 0 0 0 0
# indels 0 0 0 0 0
SRR5121079 (KY317937 – 10462 bp)
# contigs 2 2 4 29 33
Total length 10,162 10,209 9588 2569 2773
N50 5254 2255 4924 111 107
# unaligned contigs 0 0 0 11 13
Genome fraction (%) 97.132 97.582 91.617 19.853 20.340
# Ns 0 0 13 27 9
# mismatches 0 0 1 0 0
# indels 0 0 0 0 0
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primers, 47 HCoV-OC43 genome sequences were aligned using CLC
GenomicsWorkbench (Qiagen), the accession numbers of the 47 gen-
omes used are available in Supplementary material part 3. The primers
were designed in conserved regions to obtain amplicons of 500–550 bp
with a minimum overlap of 16 bp between each amplicon (after trim-
ming of primer sequences) leading to a list of 99 primer pairs (see
Supplementary material for the list of primers). In order to decrease the
number of PCR reactions, we pooled PCR primer pairs in 12 groups
each containing between 3 and 12 PCR primer pairs. The primer pairs
were grouped according to their positions on the genome avoiding too
short distance between concomitant pairs. A ﬁrst try of RT-PCR am-
plicon sequencing performed using a ﬁrst grouping of primer pairs and
ampliﬁcation eﬃciency was assessed according to the number of reads
obtained for each amplicon after quality ﬁltering. Groups were re-
organized to cluster strong ampliﬁcations in same groups and weaker
ampliﬁcations in other groups always keeping the distance criteria in
mind. This optimization of the protocol allowed to obtain an ampliﬁ-
cation for all amplicons and to minimize the diﬀerence of ampliﬁcation
eﬃciencies between amplicon within a same group and between
groups. Despite this optimization, a diﬀerence in the number of reads
per amplicon was observed from 1 to 50,000 reads between the most
sequenced amplicon and the less one during the preliminary tests.
After multiplex PCR ampliﬁcation, the PCR products from the 12
amplicon groups were mixed in equimolar proportions, a library was
prepared for each clinical sample and then sequenced (see Material and
methods section).
Distribution of variant sequences per amplicon
In order to validate that a dominant variant exists for each
amplicon, we studied the cluster size distribution, i.e. the number of
identical reads in each cluster, for each amplicon. Fig. 4 shows the
distribution of cluster sizes for the MDS4 clinical sample.
The cluster size distribution showed that the number of reads was
very diﬀerent between amplicons (Fig. 4 top panel). For example, more
than 40,000 reads were obtained for amplicon 70 and only 65 reads for
amplicon 99. However, the distribution of the reads in individual am-
plicons was relatively similar as a dominant sequence was system-
atically observed for each amplicon representing more than 50% of the
reads for 94 of the 99 amplicons (Fig. 4 bottom panel). Only amplicon
77 showed a diﬀerent proﬁle with several sequences in relatively high
proportions. The same experiment was performed for each clinical
samples leading to the same conclusions (see Supplementary material
part 4). We studied the amplicon 77 that showed a diﬀerent distribu-
tion. We compared the reads from the clusters representing high pro-
portions (more than 30 reads). Almost all reads showed diﬀerences in
the last 8 nucleotides which contained a stretch of four Ts. This region
was overlapping with the next amplicon (Amplicon 78) which did not
show this variability problem. We ﬁrst discarded analytical problem
(e.g. bad primer trimming) and we concluded that this variability was
due to an ampliﬁcation or sequencing artifact. However, this artifact
did not impact the ﬁnal built sequence in our method as the region was
also covered by another amplicon. Finally, the results showed that se-
lecting the most abundant read as the representative fragment for each
amplicon seemed to reﬂect the reality.
2.4. Sequencing of HCov-OC43 genomes from clinical samples
The complete protocol was applied to 11 clinical samples from pa-
tients infected with HCoV-OC43. The sequencing data were analyzed
Fig. 3. Coronavirus genome ampliﬁcation trials by RT-PCR for diﬀerent fragment lengths. A: Capillary electrophoresis proﬁles of RT-PCR products of the obtained
diﬀerent fragments. B: Agarose gel-like proﬁles. L: ladder with the sizes alongside (in bp); a to j: RT-PCR product from ~500p to ~5000 bp with an increment-step of
~500 bp.
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with V-ASAP. The sequencing results and metrics are shown in Table 2.
In comparison with previous studies and despite a longer genome se-
quence, the sequencing of coronavirus genome was very speciﬁc. The
number of reads that mapped against a HCoV-OC43 sequence was very
high (more than 92% for 9 of the samples), showing that the primer
design and the biological protocol led to few noise in sequencing data.
Only MDS5 and PR2 samples showed very low percentages of mapped
reads, 11.30% and 9.39% respectively, due to the fact that the major
part of reads was locally aligned against human sequences. For the 11
samples, the number of merged reads was comprised between
1,811,280 and 2,309,880 providing enough sequencing data for reli-
able analysis.
Some of our samples showed very low library quantity (MDS1,
MDS5, MDS12, MDS15, MDS16 and PR2) and a library ampliﬁcation
was needed for these samples. Sequencing depth was not uniform be-
tween amplicons along the genome: some amplicons were over-se-
quenced (until 48,000×) and some others were only sequenced a few
times or not at all. Semi-quantitative results of viral load in each sample
showed that all samples with relatively high viral load (noted as ++
and +++ in Table 2) led to a complete or nearly-complete assembly
(1 or 2 contigs covering more than 99% of the genome sequence). Two
of the samples, MDS2 and MDS4, with lower viral load (noted as + in
Table 2) also led to a complete assembly with none of their amplicons
with a depth below 10× . On the opposite, poor results were obtained
for MDS5 and PR2, leading to a ﬁnal assembly covering only 53% and
63%, respectively, of the genome sequence. The poor results obtained
Fig. 4. Study of the cluster size distribution for the 99 amplicons (PCR01 to PCR99) from the MDS4 sample. The top panel shows the number of reads for each
amplicon (in black) and the number of reads in the biggest cluster (in gray). The bottom panel shows the proportion of each clusters for each amplicon. The
proportion of the biggest cluster is in black and the proportion of clusters containing less than 1% of reads were summed up and are in gray.
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with MDS5 were probably due to a degradation of the extracted RNA.
Indeed, contrary to the other samples, it was subjected to 6 freezing/
thawing as for this patient other viruses were searched before searching
for HcoV-OC43 presence. We can postulate that the repetitive freezing/
thawing of the MDS5 sample caused the degradation of the viral RNA.
The PR2 sample is the only sample obtained by broncho-alveolar lavage
for which a lower eﬃciency of the extraction is usually observed, ex-
plaining the poor sequencing eﬃciency and so the poor resulting as-
sembly.
Using this new protocol, full-length assembled genomes (in a single
contig) were obtained for 7 out of the 11 clinical samples. For MDS15
sample, 2 contigs were obtained covering more than 99% of the entire
genome. 8 contigs leading to a ﬁnal assembly of 28,915 bp was ob-
tained for MDS1 sample for which the library concentration was not
detectable before ampliﬁcation.
3. Conclusions
Here we introduced a complete protocol called V-ASAP for whole-
genome virus sequencing based on multiplex PCR and amplicon se-
quencing, and a new reference-free analytical pipeline leading to the
sequence of the dominant viral genome. We validated our analytical
approach on published Zika data and applied the entire protocol to
sequence 11 clinical samples infected with HCoV-OC43 virus collected
at the University Hospital of Lille. V-ASAP led to a complete or a nearly
complete assembly for 9 out of the 11 samples and this even for samples
with low viral load. Contrary to classical analytical process, our method
avoids alignment biases and is able to assemble virus genome from
families presenting highly divergent sequences (only conserved regions
are necessary for primer design). It was the ﬁrst time that the multiplex
PCR method was successfully used for ampliﬁcation of a genome of
more than 30 kb. This protocol opens possibilities in the ﬁeld of mo-
lecular virology ﬁrstly because it can be easily applied to sequence and
assemble other virus genomes. It is also of particular interest to explore
over time the evolution of a virus genome during the infection process
as one can follow which variants take over the others.
4. Material and methods
4.1. Samples collection and description
Samples were collected from patients hospitalized at the University
Hospital of Lille. HCoV-OC43 RNA detection was obtained using
Anyplex II RV16 (RV16) kit (Seegene, South Korea) according to the
manufacturer's recommendations (Radko et al., 2017). Semi-quantita-
tive results are expressed on a scale from + to +++. Ten of the
samples come from nasal swab (noted ‘MDSX’) and 1 from broncho-
alveolar lavage (PR2). Viral RNA were extracted using the QIAamp
Viral RNA Mini kit (Qiagen, Courtaboeuf, France) according to the
manufacturer's protocol. RNA were eluted in 80 µl of DNAse-RNAse free
water.
4.2. Amplicon sequencing of HCoV-OC43
16 µl of extracted RNA were reversed transcribed into cDNA using
random hexamers primers (Life Technologies) and 400U of SuperScript
III reverse transcriptase enzyme (Life Technologies) during 2 h at 45 °C.
Obtained cDNA were ampliﬁed with the 2X PCR Precision Master Mix
(Applied Biological Materials Inc) and multiple primer pairs divided
into 12 groups (see primers sequence and groups in Supplementary
data). PCR conditions were 40 cycles of annealing at 60 °C for 20 s and
extension at 72 °C for 60 s. Ampliﬁed products were puriﬁed with Nu-
cleoMag NGS Clean-up and Size Select (Macherey-Nagel, Hoerdt,
France). Puriﬁed amplicons were quantiﬁed by ﬂuorimetric method
(using Qubit dsDNA HS, ThermoFisher Scientiﬁc). Amplicons from each
group were normalized to have the same equimolar concentration and
pooled together to obtain one pool per initial sample.
Sequencing libraries were prepared with 75 ng to 1 µg of pooled
DNA, using the NxSeq AmpFREE Low DNA Library Kit and Illumina-
compatible adaptors (Lucigen). Each library had a unique 6 bases index.
Libraries were quantiﬁed with the KAPA Library Quantiﬁcation Kit
Illumina Platforms (Kapa Biosystems) and checked by microﬂuidic
electrophoresis (Bioanalyzer High Sensitivity DNA Kit, Agilent
Technologies).
Before sequencing, libraries were normalized at 2 nM and pooled
(MDS2, MDS4, MDS6, MDS11 and MDS14). For samples with low li-
brary concentration (MDS1, MDS5, MDS12, MDS15, MDS16 and PR2),
libraries were ampliﬁed by 10 PCR cycles with P5/P7 primers (which
are speciﬁc of Illumina adaptors), and then normalized to 2 nM before
pooling. Libraries were paired-end sequenced (5 or 6 libraries per se-
quencing run) with 2×300 cycles on the Illumina MiSeq.
4.3. V-ASAP
Several public tools are used in V-ASAP. CASPER was used for read
merging (option -j). PhiX reads were ﬁltered out with bowtie2 (para-
meter–local). Reads were then sorted by amplicon with cutadapt (op-
tion–discard-untrimmed) and primer sequences were trimmed. For each
Table 2
Results and metrics from the sequencing of the 11 clinical samples.
Sample Viralload Number of freezing/
thawing
Library [c]
(nM)a
Mappedreads (%)b Mergedreads Amplicons
< 10readsc
Amplicons
< 100readsd
Contigse Assemblysize (bp)f
MDS1 + 3 ND (7.9) 92.03 2,270,961 25 41 8 28.915
MDS2 + 3 4.76 98.87 1,972,807 0 2 1 30.665
MDS4 + 2 6.97 99.02 1,811,280 0 3 1 30.664
MDS5 + 6 0.46 (2.10) 11.30 2,309,880 70 95 17 (+19) 16.516 (+8738)
MDS6 + 3 3.49 97.45 1,971,524 1 7 1 30.664
MDS11 +++ 2 5.77 99.03 1,973,800 0 2 1 30.665
MDS12 ++ 3 0.63 (14.10) 98.79 2,130,557 9 17 1 30.419
MDS14 ++ 4 5.34 92.51 2,164,740 0 7 1 30.664
MDS15 ++ 4 2.98 (45.20) 98.47 2,118,341 4 10 2 30.471
MDS16 ++ 3 2.43 (37) 95.81 2,180,964 4 10 1 30.668
PR2 + 3 0.29 (1.90) 9.39 2,182,806 68 81 17 (+18) 19.045 (+8062)
a ND: not detected. Numbers in brackets correspond to the concentration obtained after library ampliﬁcation.
b The “mapped reads” column shows the number of reads mapped against the KX344031 sequence after ﬁltering of PhiX control reads.
c Number of amplicons having a sequencing depth lower than 10 reads after merging.
d Number of amplicons having a sequencing depth lower than 100 reads after merging.
e Number of contigs produced with CAP3. Number of singlets are in brackets.
f Size of the ﬁnal assembly. Numbers in brackets correspond to the cumulative size of singlets.
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amplicon, reads were then clustered using CD-HIT (parameters -c 1 -d 0
-s 1). Finally the representative reads for each amplicon were assembled
with CAP3 (-o 16 -s 251 -j 31 -p 66 -i 21).
V-ASAP is freely accessible on https://github.com/caboche/V-ASAP
as a docker container.
4.4. Validation on Zika virus
Zika datasets (SRR5121076, SRR5121078, SRR5121079) were ob-
tained from SRA (NCBI). Reads were already pre-processed: primers
were trimmed and a quality control was probably performed. In our
method, primer sequences are used to assign each read to its amplicon
of origin, but in these datasets primer sequences were already trimmed
and we had to adapt our method for this step. The 22 nucleotides fol-
lowing the true forward primers designed in the original study was
considered as “fake forward primers” (the list of these 35 primers is
given in Supplementary material part 5). The reverse primers could not
be used because the read ends in SRA were trimmed for quality. The
“fake forward primers” were used as input of V-ASAP analysis with a
change in parameters of CASPER (-g 0.27 which is the threshold for
mismatch ratio of best overlap region) and the minimum read size was
ﬁxed to 350 bp in the clustering step. All the others steps of V-ASAP
remained unchanged.
To study the impact of the reference sequence selection in the
alignment-based approach, we selected four sequences based on their
increasing phylogenetic distance from the studied Zika sequences. From
the phylogenic tree (see Supplementary material part 1), we selected a
sequence close to the studied genomes (KU853012.1), a sequence a
little further but still on the same branch of the phylogenetic tree
(HQ234499.1) and two sequences more phylogenetically distant
(HQ234501.1 and KF268948.1). These 4 reference genomes were used
for alignment of reads with novoalign (-r Random -l 40 -g 40 -x 20 -t
502). The alignment BAM ﬁle was then converted into a pileup ﬁle with
Samtools mpileup command. VarScan was used with the pileup ﬁle to
generate the list of all SNPs and indels with a minimum coverage of 1
read. An home-made script was then used to call the consensus: at each
position with a minimal coverage of 8 reads, the base with a frequency
of more than 51% was called.
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